杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/01/13 | 1,319 | 1,330 | 1,316 | 1,323 | +5 | +0.4% | 52,000 |
| 2012/01/12 | 1,341 | 1,341 | 1,316 | 1,318 | -29 | -2.2% | 79,000 |
| 2012/01/11 | 1,344 | 1,354 | 1,333 | 1,347 | -6 | -0.4% | 126,000 |
| 2012/01/10 | 1,367 | 1,377 | 1,351 | 1,353 | ±0 | ±0% | 117,000 |
| 2012/01/06 | 1,377 | 1,377 | 1,350 | 1,353 | -14 | -1% | 122,000 |
| 2012/01/05 | 1,377 | 1,382 | 1,339 | 1,367 | -10 | -0.7% | 58,000 |
| 2012/01/04 | 1,375 | 1,387 | 1,372 | 1,377 | +22 | +1.6% | 136,000 |
| 2011/12/30 | 1,345 | 1,364 | 1,337 | 1,355 | +10 | +0.7% | 48,000 |
| 2011/12/29 | 1,335 | 1,355 | 1,318 | 1,345 | +6 | +0.4% | 128,000 |
| 2011/12/28 | 1,344 | 1,344 | 1,317 | 1,339 | -5 | -0.4% | 71,000 |
| 2011/12/27 | 1,351 | 1,351 | 1,340 | 1,344 | +2 | +0.1% | 35,000 |
| 2011/12/26 | 1,344 | 1,350 | 1,337 | 1,342 | -16 | -1.2% | 117,000 |
| 2011/12/22 | 1,368 | 1,372 | 1,354 | 1,358 | -8 | -0.6% | 130,000 |
| 2011/12/21 | 1,359 | 1,366 | 1,348 | 1,366 | +29 | +2.2% | 55,000 |
| 2011/12/20 | 1,341 | 1,343 | 1,331 | 1,337 | -11 | -0.8% | 98,000 |
| 2011/12/19 | 1,358 | 1,358 | 1,334 | 1,348 | +18 | +1.4% | 152,000 |
| 2011/12/16 | 1,326 | 1,349 | 1,324 | 1,330 | +8 | +0.6% | 88,000 |
| 2011/12/15 | 1,314 | 1,327 | 1,314 | 1,322 | -8 | -0.6% | 97,000 |
| 2011/12/14 | 1,322 | 1,335 | 1,321 | 1,330 | -6 | -0.4% | 120,000 |
| 2011/12/13 | 1,346 | 1,351 | 1,334 | 1,336 | -18 | -1.3% | 73,000 |
| 2011/12/12 | 1,351 | 1,358 | 1,347 | 1,354 | +5 | +0.4% | 79,000 |
| 2011/12/09 | 1,354 | 1,354 | 1,338 | 1,349 | -1 | -0.1% | 122,000 |
| 2011/12/08 | 1,344 | 1,366 | 1,340 | 1,350 | +8 | +0.6% | 190,000 |
| 2011/12/07 | 1,360 | 1,361 | 1,330 | 1,342 | +24 | +1.8% | 221,000 |
| 2011/12/06 | 1,324 | 1,338 | 1,317 | 1,318 | -11 | -0.8% | 228,000 |
| 2011/12/05 | 1,321 | 1,334 | 1,318 | 1,329 | +25 | +1.9% | 133,000 |
| 2011/12/02 | 1,283 | 1,337 | 1,283 | 1,304 | +23 | +1.8% | 139,000 |
| 2011/12/01 | 1,322 | 1,325 | 1,280 | 1,281 | -14 | -1.1% | 193,000 |
| 2011/11/30 | 1,288 | 1,297 | 1,280 | 1,295 | +13 | +1% | 136,000 |
| 2011/11/29 | 1,283 | 1,288 | 1,270 | 1,282 | +10 | +0.8% | 134,000 |
| 2011/11/28 | 1,284 | 1,288 | 1,256 | 1,272 | -12 | -0.9% | 112,000 |
| 2011/11/25 | 1,318 | 1,328 | 1,282 | 1,284 | -4 | -0.3% | 233,000 |
| 2011/11/24 | 1,300 | 1,307 | 1,281 | 1,288 | -26 | -2% | 110,000 |
| 2011/11/22 | 1,329 | 1,331 | 1,304 | 1,314 | -15 | -1.1% | 115,000 |
| 2011/11/21 | 1,320 | 1,338 | 1,314 | 1,329 | +9 | +0.7% | 185,000 |
| 2011/11/18 | 1,300 | 1,341 | 1,300 | 1,320 | -12 | -0.9% | 268,000 |
| 2011/11/17 | 1,355 | 1,355 | 1,326 | 1,332 | -25 | -1.8% | 158,000 |
| 2011/11/16 | 1,372 | 1,373 | 1,344 | 1,357 | -15 | -1.1% | 102,000 |
| 2011/11/15 | 1,369 | 1,376 | 1,352 | 1,372 | +5 | +0.4% | 153,000 |
| 2011/11/14 | 1,369 | 1,390 | 1,360 | 1,367 | -8 | -0.6% | 159,000 |
| 2011/11/11 | 1,400 | 1,401 | 1,367 | 1,375 | -24 | -1.7% | 148,000 |
| 2011/11/10 | 1,394 | 1,426 | 1,394 | 1,399 | -20 | -1.4% | 148,000 |
| 2011/11/09 | 1,410 | 1,425 | 1,397 | 1,419 | +12 | +0.9% | 113,000 |
| 2011/11/08 | 1,424 | 1,432 | 1,386 | 1,407 | -5 | -0.4% | 197,000 |
| 2011/11/07 | 1,428 | 1,433 | 1,409 | 1,412 | -13 | -0.9% | 130,000 |
| 2011/11/04 | 1,435 | 1,442 | 1,422 | 1,425 | +16 | +1.1% | 115,000 |
| 2011/11/02 | 1,414 | 1,431 | 1,401 | 1,409 | -14 | -1% | 100,000 |
| 2011/11/01 | 1,428 | 1,443 | 1,423 | 1,423 | -30 | -2.1% | 103,000 |
| 2011/10/31 | 1,452 | 1,493 | 1,450 | 1,453 | -16 | -1.1% | 152,000 |
| 2011/10/28 | 1,474 | 1,489 | 1,454 | 1,469 | +17 | +1.2% | 296,000 |
3151～
3200
件表示中 / 3587件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,500円 | +3.2% | +4.5% | 3.48% | 17.18倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,100円 | +13.6% | +29.2% | 2.05% | 11.62倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,600円 | +197.7% | - | 0.00% | 46.42倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,100円 | -3.7% | -36.7% | 2.77% | 23.74倍 | 1.55倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 210,500円 | +0.4% | -8.4% | 2.52% | 27.83倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
